108
Views
13
CrossRef citations to date
0
Altmetric
Diabetes

Cardiovascular effects of sodium–glucose cotransporter 2 inhibitors: multiple actions

, &
Pages 1513-1514 | Received 31 May 2016, Accepted 31 May 2016, Published online: 14 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Niki Katsiki, Kalliopi Kotsa & Vasilios Kotsis. (2020) Empagliflozin effects on cardiac remodeling: re-shaping the future of heart failure prevention. Expert Review of Cardiovascular Therapy 18:11, pages 841-842.
Read now
Niki Katsiki, Francesco Purrello, Costas Tsioufis & Dimitri P. Mikhailidis. (2017) Cardiovascular disease prevention strategies for type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy 18:12, pages 1243-1260.
Read now

Articles from other publishers (11)

Niki Katsiki, Paschalis Steiropoulos, Nikolaos Papanas & Dimitri P. Mikhailidis. (2019) Diabetes Mellitus and Chronic Obstructive Pulmonary Disease: An Overview. Experimental and Clinical Endocrinology & Diabetes 129:10, pages 699-704.
Crossref
Niki Katsiki, Kalliopi Kotsa, Anca P. Stoian & Dimitri P. Mikhailidis. (2020) Hypoglycaemia and Cardiovascular Disease Risk in Patients with Diabetes. Current Pharmaceutical Design 26:43, pages 5637-5649.
Crossref
Golnaz Ranjbar, Dimitri P. Mikhailidis & Amirhossein Sahebkar. (2019) Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!. Metabolism 101, pages 154001.
Crossref
Genovefa D. Kolovou, Gerald F. Watts, Dimitri P. Mikhailidis, Pablo Pérez-Martínez, Samia Mora, Helen Bilianou, George Panotopoulos, Niki Katsiki, Teik C. Ooi, José Lopez-Miranda, Anne Tybjærg-Hansen, Nicholas Tentolouris & Børge G. Nordestgaard. (2019) Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review. Current Vascular Pharmacology 17:5, pages 515-537.
Crossref
Niki Katsiki, George Dimitriadis, George Hahalis, Nikolaos Papanas, Nikolaos Tentolouris, Filippos Triposkiadis, Vasilios Tsimihodimos, Costas Tsioufis, Dimitri P. Mikhailidis & Christos Mantzoros. (2019) Sodium-glucose co-transporter-2 inhibitors (SGLT2i) use and risk of amputation: an expert panel overview of the evidence. Metabolism 96, pages 92-100.
Crossref
Niki Katsiki & Filippos Triposkiadis. (2019) Resistance to Diuretics in Heart Failure: Any Role for Empagliflozin?. Current Vascular Pharmacology 17:4, pages 421-424.
Crossref
Munehisa Bekki, Nobuhiro Tahara, Atsuko Tahara, Sachiyo Igata, Akihiro Honda, Yoichi Sugiyama, Tomohisa Nakamura, Jiahui Sun, Yuki Kumashiro, Takanori Matsui, Yoshihiro Fukumoto & Sho-ichi Yamagishi. (2019) Switching Dipeptidyl Peptidase-4 Inhibitors to Tofogliflozin, a Selective Inhibitor of Sodium-Glucose Cotransporter 2 Improve Arterial Stiffness Evaluated by Cardio-Ankle Vascular Index in Patients with Type 2 Diabetes: A Pilot Study. Current Vascular Pharmacology 17:4, pages 411-420.
Crossref
Habib Yaribeygi, Stephen L. Atkin, Niki Katsiki & Amirhossein Sahebkar. (2018) Narrative review of the effects of antidiabetic drugs on albuminuria. Journal of Cellular Physiology 234:5, pages 5786-5797.
Crossref
Habib Yaribeygi, Stephen L. Atkin & Amirhossein Sahebkar. (2019) Mechanistic effects of SGLT2 inhibition on blood pressure in diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13:2, pages 1679-1683.
Crossref
Habib Yaribeygi, Niki Katsiki, Behzad Behnam, Helia Iranpanah & Amirhossein Sahebkar. (2018) MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment. Metabolism 87, pages 48-55.
Crossref
Niki Katsiki, Dimitri P Mikhailidis & Maciej Banach. (2018) Leptin, cardiovascular diseases and type 2 diabetes mellitus. Acta Pharmacologica Sinica 39:7, pages 1176-1188.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.